Search results

Donor government negotiators are considering scrapping the global aid monitoring system that keeps donors honest and improves the quality of their foreign assistance, Oxfam warns.

Government negotiators meeting in Busan, South Korea are working through the night in a last ditch effort to reach a deal on the future of global aid

Anna Marriott, Oxfam Health Policy Manager and Policy co-lead for the People’s Vaccine Alliance said: "The 2021 Global Health Summit ended today in danger of being judged an historical failure of global solidarity to tackle a Covid-19 pandemic that is still, around the world, in its first expanding phase and yet to peak."

The slight decrease in development aid spending in 2017 is bad news for the fight to end poverty and reduce inequalities, said Oxfam today in response to the publication of new aid figures by the Organisation for Economic Cooperation and Development (OECD).

In reaction to today’s UN 2023 Global Humanitarian Outlook report, revealing that 339 million people are in urgent need of humanitarian aid - the highest caseload in history -  Oxfam’s Global Humanitarian Director Marta Valdes Garcia said: “One in every 23 people around the world –the equivalent of nearly half of the entire population of Europe– is now in urgent need of humanitarian aid. This news must be an immediate wake-up call. 

The European Union has adopted a new approach to foreign policy dubbed the “Global Gateway,” supported by a new European Financial Architecture for Development (EFAD). These policies are a direct response to the state of permacrises that the world finds itself in. It seeks to inject 180-300 billion euros over a period of six years into the EU’s partner countries in the form of infrastructure projects, a green transition and digitalisation. 

In response to Merck’s announcement that it has granted a license for its promising COVID-19 pill to the Medicines Patent Pool, Robbie Silverman, Oxfam America’s Senior Manager for Private Sector Engagement, made the following statement: “Merck’s move to license molnupiravir is welcome as it could indeed mean increased access to its promising COVID-19 drug in the poorest countries in the world.

The European Union is rumored to be preparing just a token handout for climate action in poor countries for the next three years, with no guarantee that this money is going to come on top of existing aid commitments.

This report examines the impact of the global financial crisis on the budgets of low-income countries, especially their spending to reach the Millennium Development Goals (MDG).

As development leaders from around the world gather in Mexico City to participate in the first High Level Meeting of the Global Partnership for Effective Development Cooperation this week, Oxfam is asking a crucial question: What will be Mexico’s legacy?